Since STAT1/STAT3 signaling is regarded as one of the critical pathways for cell proliferation, migration, and invasion [36,37], it is likely that the anticancer effects of hesperidin are mediated by STAT1/STAT3 signaling and activated by treatment with IFN-γ in the oral cancer cell lines. This evidence concerns the gene IFNG and lip and oral cavity carcinoma.